The spike-ACE2 interaction underlying SARS-CoV-2 infection and inhibition is enhanced by intermolecular cross linking

The spike-ACE2 interaction underlying SARS-CoV-2 infection and inhibition is enhanced by intermolecular cross linking

Visa andra versioner (1)

Bibliografiska uppgifter
Huvudupphovsmän:	Asor, R, Olerinyova, A, Kushwah, MS, Soltermann, F, Rudden, LP, Vasiljevic, S, Brun, J, Hensen, M, Hill, M, Degiacomi, M, Zitzmann, N, Struwe, WB, Kukura, P
Materialtyp:	Conference item
Språk:	English
Publicerad:	Cell Press 2022

Liknande verk

The spike-ACE2 interaction underlying SARS-CoV-2 infection and inhibition is enhanced by intermolecular cross linking
av: Asor, R, et al.
Publicerad: (2022)

Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition
av: Asor, R, et al.
Publicerad: (2024)

Cooperativity and induced oligomerization control the interaction of SARS-CoV-2 with its cellular receptor and patient-derived antibodies
av: Asor, R, et al.
Publicerad: (2024)

Assessing antigen structural integrity through glycosylation analysis of the SARS-CoV-2 viral spike
av: Brun, J, et al.
Publicerad: (2021)

Label-free methods for optical in vitro characterization of protein–protein interactions
av: Soltermann, F, et al.
Publicerad: (2021)

Assessing Antigen Structural Integrity through Glycosylation Analysis of the SARS-CoV‑2 Viral Spike
av: Juliane Brun, et al.
Publicerad: (2021-03-01)

Interfacial subregions of SARS-CoV-2 spike RBD to hACE2 affect intermolecular affinity by their distinct roles played in association and dissociation kinetics
av: Xiangwu Tang, et al.
Publicerad: (2024-12-01)

Quantifying binding affinities, kinetics and stoichiometry of biomolecular complexes with mass photometry
av: Soltermann, F, et al.
Publicerad: (2020)

Lifting the concentration limit of mass photometry by PEG nanopattering
av: Kratochvil, J, et al.
Publicerad: (2024)

Molecular Aspects of Spike–ACE2 Interaction
av: Luigi De Masi, et al.
Publicerad: (2022-01-01)

Spike residue 403 affects binding of coronavirus spikes to human ACE2
av: Fabian Zech, et al.
Publicerad: (2021-11-01)

Single molecule mass photometry of nucleic acids
av: Li, Y, et al.
Publicerad: (2020)

Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism
av: Riadh Badraoui, et al.
Publicerad: (2021-01-01)

Mass photometry of membrane proteins
av: Olerinyova, A, et al.
Publicerad: (2020)

Label-free single-molecule quantification of DNA by mass photometry
av: Li, Y, et al.
Publicerad: (2020)

Coarse-Grained Modeling of Coronavirus Spike Proteins and ACE2 Receptors
av: Timothy Leong, et al.
Publicerad: (2021-06-01)

Quantifying protein-protein interactions by molecular counting with mass photometry
av: Soltermann, F, et al.
Publicerad: (2020)

Molecular docking between human TMPRSS2 and SARS-CoV-2 spike protein: conformation and intermolecular interactions
av: Mushtaq Hussain, et al.
Publicerad: (2020-09-01)

Engineer RNA-protein nanowires as light-responsive biomaterials
av: Younas, T, et al.
Publicerad: (2023)

Binding affinity between coronavirus spike protein and human ACE2 receptor
av: Marcus Ho-Hin Shum, et al.
Publicerad: (2024-12-01)

Characterising biomolecular interactions and dynamics with mass photometry
av: Asor, R, et al.
Publicerad: (2022)

Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
av: Huo, J, et al.
Publicerad: (2020)

CEBIT screening for inhibitors of the interaction between SARS-CoV-2 spike and ACE2
av: Gaofeng Pei, et al.
Publicerad: (2022-07-01)

Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
av: Changhai Lei, et al.
Publicerad: (2020-04-01)

Mass Photometry of Membrane Proteins
av: Olerinyova, A, et al.
Publicerad: (2020)

Engaging the spikes: heparan sulfate facilitates SARS-CoV-2 spike protein binding to ACE2 and potentiates viral infection
av: Rajkumar Singh Kalra, et al.
Publicerad: (2021-01-01)

Discovery of Clioquinol and analogues as novel inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 infection, ACE2 and ACE2 - Spike protein interaction in vitro
av: Omonike A. Olaleye, et al.
Publicerad: (2021-03-01)

Bromelain inhibits SARS‐CoV‐2 infection via targeting ACE‐2, TMPRSS2, and spike protein
av: Satish Sagar, et al.
Publicerad: (2021-02-01)

Temperature-dependent Spike-ACE2 interaction of Omicron subvariants is associated with viral transmission
av: Mehdi Benlarbi, et al.
Publicerad: (2024-08-01)

Discovery of novel spike/ACE2 inhibitory macrocycles using in silico reinforcement learning
av: Lev Shapira, et al.
Publicerad: (2022-12-01)

Evolution of SARS-CoV-2 Spikes shapes their binding affinities to animal ACE2 orthologs
av: Weitong Yao, et al.
Publicerad: (2023-12-01)

Pyroptosis of syncytia formed by fusion of SARS-CoV-2 spike and ACE2-expressing cells
av: Huabin Ma, et al.
Publicerad: (2021-08-01)

Endothelial glycocalyx shields the interaction of SARS-CoV-2 spike protein with ACE2 receptors
av: Marta Targosz-Korecka, et al.
Publicerad: (2021-06-01)

Discovery of human ACE2 variants with altered recognition by the SARS-CoV-2 spike protein.
av: Pete Heinzelman, et al.
Publicerad: (2021-01-01)

ACE2-cytomimetic particles restrict SARS-Cov-2 spike protein binding to cellular targets
av: Thomas A. Strong, et al.
Publicerad: (2021-12-01)

Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule level
av: Rong Zhu, et al.
Publicerad: (2022-12-01)

SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication
av: Augusto C. Montezano, et al.
Publicerad: (2023-08-01)

Mutants of human ACE2 differentially promote SARS-CoV and SARS-CoV-2 spike mediated infection.
av: Nidhi Shukla, et al.
Publicerad: (2021-07-01)

Anti-Fungal Drug Anidulafungin Inhibits SARS-CoV-2 Spike-Induced Syncytia Formation by Targeting ACE2-Spike Protein Interaction
av: Shahzaib Ahamad, et al.
Publicerad: (2022-03-01)

Biobox: a toolbox for biomolecular modelling
av: Rudden, LSP, et al.
Publicerad: (2021)